Objective-Evaluate glucose control and clinical outcomes in diabetic burn ICU patients.
Introduction
Since 2001, multiple investigators have demonstrated that hyperglycemia is associated with poorer clinical outcomes and increased mortality in a variety of critically ill medical and surgical patient populations1 -12. More recently, poorer clinical outcomes and increased mortality have not only been associated with hyperglycemia but also with high blood glucose variability and loss of blood glucose profile complexity13 -16 . Intensive insulin therapy has been adopted as the best way to minimize hyperglycemia and its associated clinical outcomes in many medical and surgical critical care settings. As of 2008 approximately 73% of American Burn Association (ABA) verified burn centers in the United States had implemented intensive insulin therapy protocols 17 .
Critically ill burn patients, compared to other trauma patients, exhibit extreme physiologic and metabolic derangements18 -19. The presence of hyperglycemia after burns has been associated with a state of great physiologic and metabolic stress since the 1930s and is referred to as stress-induced hyperglycemia, pseudodiabetes of burns, or burns-stress diabetes18 -21 . However, only patient age and total body surface area (TBSA) burned have been directly associated with mortality in most critically ill burn patient populations 22-24. Like hyperglycemia, the role of diabetes in critical illness has been documented. Yet, the association between a pre-existing diagnosis of diabetes and clinical outcomes in critically ill adults is still not clear. Several authors have asserted that critically ill medical and surgical patients with a pre-existing diagnosis of diabetes are more likely to have infectious complications, worse clinical outcomes, and increased mortality [25] [26] [27] [28] [29] [30] [31] . Others have suggested that only hyperglycemia, not a pre-existing diagnosis of diabetes, is associated with infectious complications, worse clinical outcomes, and increased mortality in critically ill patients [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] . While hyperglycemia has been associated with increased mortality after burn injury 10,12, 19 -21 a pre-existing diagnosis of diabetes has only been associated with infectious complications and poorer clinical outcomes in critically ill burn patients39 -40 .
Recognizing the relative lack of data on diabetic burn intensive care unit (ICU) patients, we investigated the association between a pre-existing diagnosis of diabetes, blood glucose control, clinical outcomes, and mortality in critically ill burn patients.
Methods
After figure 1 ). Hyperglycemia for all patients in the burn ICU was treated using intensive insulin therapy with a target blood glucose level of 80-110mg/dL.
All demographic, blood glucose, and clinical outcomes data were obtained from each patient's electronic medical record via a database query performed by the USAISR information technology department. Analyzed demographic data consisted of age, gender, diabetes status, injury severity score (ISS), and total body surface area (TBSA) burned. Subjects were labeled as diabetic if they had a diagnosis of diabetes documented in their medical records. Otherwise they were labeled as non-diabetic. Admission blood glucose values were collected from admission chemistry and electrolyte laboratory panels. All other glucose values were obtained from bedside point-of-care glucometers and arterial blood gas measurement devices. Our institution has previously demonstrated that anemia evidenced by low hematocrit levels is associated with falsely elevated point-of-care glucometer values potentially masking hypoglycemia41. However, while most of the point-of-care glucose values analyzed in our study were corrected for the hematocrit effect42, some were not. As a result, both corrected and uncorrected glucose values were included in the study since both types of values were used by the burn ICU nurses for patient care. After all blood glucose values had been obtained, mean glucose levels for each subject were calculated for his/her entire hospital stay. Blood glucose variability for each subject was derived by calculating a percent coefficient of variation (standard deviation divided by the mean then multiplied by 100). Mean daily blood glucose level for each subject was calculated using daily blood glucose levels averaged over the entire hospital stay. Mean AM blood glucose level for each subject was calculated using blood glucose levels that were drawn from 4AM to 8AM and averaged over the entire hospital stay. The frequency of hypoglycemia was assessed by dividing the number of hypoglycemic measurements, defined as <80mg/dL, by the total number of measurements for each subject. The efficacy of intensive insulin therapy was calculated by dividing the number of out-of-range blood glucose measurements (<80mg/dL or >110mg/dL) by the total number of blood glucose measurements for each subject. Clinical outcomes data was collected from each patient's electronic medical record. Primary outcome measures that were investigated were ventilator days, ventilator-free days (30 day maximum), ICU days, ICU-free days (30 day maximum), hospital days, hospital-free days (60 day maximum), and mortality. Ventilator-free days, ICU-free days, and hospital-free days were calculated by subtracting ventilator days, ICU days, and hospital days from 30, 30, and 60, respectively. Once all the demographic, blood glucose, and clinical outcomes data had been compiled, we created a study database using Excel and Access (Microsoft, Redmond, WA) which facilitated data integrity verification and data analysis.
Statistical analysis was performed by using the SPSS statistical analysis software package (International Business Machines, Chicago, IL). Diabetics were compared to non-diabetics. Differences between groups with regards to gender, diabetic status, number of subjects with TBSA>20%, number of subjects with full thickness (3 rd degree burns), and mortality were calculated using Chi-square analysis (p≤0.05). Due to the non-parametric distribution of the data Mann-Whitney U tests were employed to analyze differences between groups with regards to age, admission blood glucose level, mean blood glucose level, blood glucose variance, , mean daily blood glucose level, mean 6AM blood glucose level, percent of measurements that were hypoglycemic, percent of measurements that were out of range (80-110mg/dL), ISS, TBSA, ventilator days, ventilator-free days, ICU days, ICU-free days, hospital days, and hospital-free days (p≤0.05). Clinical variables that were significantly different between survivors and non-survivors were input into regression models to determine each variable's contribution to clinical outcomes. Multivariate linear regression models were used to analyze the effects of those variables on ventilator-free days, ICU-free days, and hospital-free days (p≤0.05). Similarly, a multivariate logistic regression model was used to analyze the influence of those same variables on mortality (p≤0.05).
Results
The total number of patients admitted to the burn ICU with burn injuries from January 1, 2006 to December 31, 2009 was 744. A total of 462 subjects satisfied the inclusion criteria and were included in the study. Of these 462 subjects, 57 (12%) had a pre-existing diagnosis of diabetes documented in their medical records upon admission to the burn ICU and 405 subjects (88%) did not have any documented medical history of diabetes. Out of the 109,930 blood glucose measurements that were analyzed for all subjects, 67,193 were corrected for the hematocrit effect whereas 42,737 were not. Sixty-five (14%) of the subjects died and 397 (86%) of the subjects lived.
Subjects with a pre-existing diagnosis of diabetes were older and had higher admission blood glucose levels, mean blood glucose levels, blood glucose variability, mean daily blood glucose levels, mean AM blood glucose levels, number of hypoglycemic measurements, and out-of-range blood glucose measurements compared to non-diabetics (table 1) . ISS, TBSA, number of subjects with TBSA>20%, and number of subjects with full thickness (3 rd degree) burns was not significantly different between subjects with a pre-existing diagnosis of diabetes and non-diabetics (table 1) . Ventilator-free days and hospital-free days were not different but ICU-free days were fewer in subjects with a pre-existing diagnosis of diabetes as computed by univariate statistical analysis (table 1) . More subjects in the diabetic group died (21%) compared to those in the non-diabetic group (13%). This difference was not statistically significant (table 1) .
To assess the effects of confounding factors on clinical outcomes, subjects who survived were compared to subjects who died. Non-survivors were older and had higher admission blood glucose levels, mean blood glucose levels, blood glucose variability, ISS, and TBSA compared to survivors (table 2) . The non-survivor group had a greater number of subjects with a pre-existing diagnosis of diabetes (18%) compared to the non-survivor group (11%). This difference was not statistically significant, however (table 2) . Age, gender, ISS, TBSA, admission blood glucose levels, mean blood glucose levels, blood glucose variability, and diabetes diagnosis status were input into multivariate linear and logistic regression models. The number of ventilator-free days, ICU-free days, and hospital-free days was affected by age, ISS, TBSA, admission blood glucose levels, and mean blood glucose levels (tables 3-5). Blood glucose variability was associated with hospital-free days only ( 
Discussion
Hyperglycemia at the time of admission to the ICU, poor ICU blood glucose control, and increased blood glucose variability are associated with clinical outcomes and increased mortality in a variety of critically ill medical and surgical patients [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [19] [20] [21] [26] [27] [29] [30] [31] 33, [35] [36] [37] [38] . The findings of admission hyperglycemia and ICU hyperglycemia in our study of burn patients are consistent with the stress-induced hyperglycemia and pseudodiabetes of burns that are widely known to occur in all critically ill burn patients [18] [19] [20] [21] . After admission to the burn ICU, patients received intensive insulin therapy with a target blood glucose level of 80-110mg/dL to treat their hyperglycemia. When comparing the diabetics to the nondiabetics in our study population, we found that the burn patients with a pre-existing diagnosis of diabetes were older with higher admission blood glucose levels, higher mean blood glucose levels, and increased blood glucose variability when compared to the critically ill burn patients without a pre-existing diagnosis of diabetes. Our findings are consistent with previous studies that examine hyperglycemia in patients with burn injuries [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [39] [40] and indicate that blood glucose control in our critically ill burn patients is difficult from the moment that they are injured and admitted to the burn ICU. However, our study is limited because we did not have a reliable method to confirm the history of diabetes in our patients. Regardless, using patients' past medical history to identify diabetic and nondiabetic patients should at least capture those patients who would be most severely affected by diabetes or for whom this information would be available according to the current standard of care. The finding of no difference even in this identified population with presumably more severe disease suggests that a pre-existing diagnosis of diabetes has minimal effects on outcomes in the severely burned. This may be due to the finding that glucose control is almost universally altered after severe injury even in those who were previously normal, thus, all become "diabetic". The risk of type II error also exists; however, the population is of enough size that a potential factor with a large contribution should have been detected.
Although the effect of hyperglycemia on clinical outcomes and mortality in burn patients is apparent, the effect of diabetes on the same patient population is still unclear and controversial 10-21, 39-40 . As mentioned above, hyperglycemia in the ICU is associated with poor clinical outcomes and increased mortality 1-12, 19-21, 26-27, 29-31, 33, 35-38 . However, it is unclear why patients with a pre-existing diagnosis of diabetes who have consistently elevated blood glucose levels do not have worse clinical outcomes compared to nondiabetics in our study. This phenomenon has previously been demonstrated by Egi et al and the NICE-SUGAR investigators who showed that hyperglycemia in critically ill diabetic patients is likely biologically different than in non-diabetics and therefore does not significantly influence clinical outcomes and mortality as expected 36, 43 . Clinical outcomes measured by ventilator-free days, hospital-free days, and mortality were not different between the diabetic and non-diabetic burn ICU patients in our study. The diabetic group had fewer ICU-free days compared to the non-diabetic group and this was the only clinical outcome measure that was different between the two groups. This result is similar to results from previous investigators who demonstrated a positive relationship between pre-existing diabetes and worse clinical outcomes in a variety of critically ill patients 25, 27-31, 33-35, 39-40 . This consistency is not surprising since the patients from our study and the patients from the previous positive studies are demographically similar and have similar illness severities.
On the other hand, a pre-existing diagnosis of diabetes had a negative relationship with our study's other clinical outcomes and did not influence ventilator-free days, hospital-free days, and mortality in our critically ill burn patients. These negative findings are consistent with previous studies that have demonstrated no relationship between pre-existing diabetes, clinical outcomes, and mortality in critically ill patients 25, 28-29, 31-37, 38-40 . The lack of a significant relationship between diabetes and outcomes in our study and in previous studies is most likely the result of other clinical factors, such as age, ISS, and TBSA, overwhelming the effects of pre-existing diabetes. This scenario is highly plausible since the patients in the previous studies are similar to the patients in our study in terms of demographics and illness severity. Finally, our study is different from the studies that report a positive relationship between pre-existing diabetes and increased mortality [26] [27] 30 . Unlike our study's patients, the patients in Langdon's27 and Smiley's30 studies were pre-operative, peri-operative, and post-operative surgical patients who were not necessarily critically ill during their hospitalization. Capes 26 only demonstrated an association between pre-existing diabetes and mortality in critically ill patients whose diabetes was poorly controlled (≥180mg/dL). We did not know the quality and extent of pre-hospital blood glucose control in any of our patients, which is one of our study's limitations. Similarly, a recent study by Vincent et al about diabetes and increased ICU mortality does not examine the quality of pre-hospital blood glucose control either 34 . Pre-hospital blood glucose control can be determined using admission hemoglobin A1c levels which reflect the average blood glucose level for the previous 8-12 weeks. Hemoglobin A1c levels should be drawn at the time patients are admitted to the burn ICU so that they can be stratified into well-controlled, poorly controlled, and undiagnosed diabetics. After stratification each group can be studied to determine if the quality of pre-hospital blood glucose control contributes to clinical outcomes and mortality in diabetic burn ICU patients. Moreover, knowledge of a patient's admission hemoglobin A1c level would also help physicians and nurses determine the quality of pre-hospital blood glucose control and predict inpatient blood glucose physiology and clinical outcomes44 -50.
Conclusions
Burn patients with a pre-existing diagnosis of diabetes have higher blood glucose levels at time of admission to the burn ICU. They also have higher mean blood glucose levels and increased blood glucose variability during their ICU stay that indicates managing and controlling their blood glucose levels is difficult even with intensive insulin therapy. A preexisting diagnosis of diabetes does not appear to influence selected clinical outcomes as demonstrated in this retrospective study. Consort diagram for subject selection. Table 4 Multivariate linear regression model for ICU-free days (p≤0.05). β= beta coefficient; SE=standard error; CI=95% confidence interval for β coefficient
ICU-free days

